Dr. Marjolaine Baldo joined Agendia NV in May 2016 as the company’s EMEA Commercial Vice President, bringing more than 13 years of commercial business expansion experience with direct sales establishment and management in German, French, and Spanish European speaking countries, in the UK and in the Nordics. Most recently she served for 10 years as Diagnostics Sales Director of GATC Biotech, the European market leader of Next Generation Sequencing services, commercializing Solid Tumor Molecular Profiling services and Liquid Biopsies testing. Prior to this position, she was sales manager of Beckman Coulter Genomics French subsidiary, Genome Express, for 3 years.

Marjolaine earned a Molecular Biology PhD in 2003 from University Joseph Fourier (Grenoble, France) with Pre-doctoral position at the School of Medicine of Reno (Nevada, US) under the mentoring of Pr. K.M Sanders. She also earned a Bioinformatics Master’s degree at the University of Luminy (Marseille, France) and an Executive MBA at Kedge Business School (Marseille, France) in 2012.